RDD Online | Contact Us | FAQ | Join Mailing List
Palais des Congres d'Antibes
Nice (Antibes), France
April 25-28, 2017

Thursday, April 27, 2017

7.30 a.m.

Registration and Welcome Coffee

8.30 a.m.

 

Scientific Poster Session & Technology Exhibition

Sponsors:   3M Drug Delivery Systems and Catalent
Moderator: Richard N. Dalby, Ph.D. 

Scientific Posters & Exhibit Tables will be available for viewing between 8.30 a.m. and 6.00 p.m.

Session 3:

Can Connected Devices Improve Respiratory Outcomes?

Sponsor:    H&T Presspart
Moderator: Stephen P. Stein, Ph.D.

8.30 a.m.

Connecting Professionals and Patients:  How Technology can Support Asthma Self-Management
Hilary Pinnock, M.D.,
University of Edinburgh, Edinburgh, United Kingdom

9.00 a.m.

Respiratory Acoustics: An Objective Assessment of Adherence to Inhalers in Patients with COPD
Richard W Costello, M.D.,
Royal College of Surgeons in Ireland, Dublin, Ireland

9.30 a.m.

‘Track and Remind’: Can Connected Devices Improve Patient Adherence?
Garth Sutherland, M.Sc., Adherium, Auckland, New Zealand

10.00 a.m.

Asthma Mobile Health Study: Engaging Patients in Asthma Self Management
Yu-Feng Y Chan, M.D. Ph.D.,
Icahn School of Medicine at Mount Sinai, New York, USA

10.30 a.m.

Refreshments, Scientific Poster Session & Technology Exhibition

Session 4:

Posters on the Podium

Sponsor:     MEGGLE
Moderators: Joanne Peart, Ph.D., and Paul M. Young, Ph.D.

11.00 a.m.

Posters on the Podium

Five poster authors will be selected to summarize their work and answer questions during a fast-paced interactive podium session.

11.05 a.m.

High-efficiency Delivery Of Aerosols Via An Infant Nasal Cannula
Susan Boc, B.Sc.
Virginia Commonwealth University, Richmond, Virginia, USA 

11.15 a.m.

Proof of Concept of the VITROCELL® Dry Powder Chamber: A New In Vitro Test System for the Controlled Deposition of Aerosol Formulations
Marius Hittinger, Ph.D.
PharmBio Tec, Saarbrücken, Germany 

11.25 a.m.

Validating a Realistic Physical Airway Model to Investigate In Vitro Drug Deposition, Dissolution, and Epithelial Transport of Orally Inhaled Products
Bao Huynh, B.Sc.
Woolcock Institute of Medical Research, Sydney, Australia 

11.35 a.m.

Comparison of Three Aqueous Aerosol Inhalation Devices for Delivering Anti-Tuberculosis Bacteriophage D29
Nicholas Carrigy, M.Eng.
University of Alberta, Edmonton, Alberta, Canada 

11.45 a.m.

 

Environmental Assessment of Metered Dose Inhaler Propellant: Potential For a Reduced Carbon Footprint Alternative
Adisa Azapagic, Ph.D.
University of Manchester, Manchester, United Kingdom 

12.00 p.m.

Presentation of VCU RDD Peter R. Byron Graduate Student Award

12.00 p.m.

Lunch, Scientific Poster Session & Technology Exhibition

Session 5

Changing Regulations in Europe

Sponsor:    Bespak
Moderator: John N. Pritchard, Ph.D.

2.00 p.m.

New European Medical Device Regulations: Implications for Orally Inhaled and Nasal Drug Products
Maria E. Donawa, M.D.,
Donawa Lifescience Consulting, Rome, Italy

2.30 p.m.

Licensing Medicines: Consequences of the UK “Brexit Vote” to leave the European Union
David Jefferys, M.D.,
Eisai Europe, Hatfield, United Kingdom

3.00 p.m.

Refreshments, Scientific Poster Session & Technology Exhibition

Session 6

Achieving Deposition Equivalence

Sponsor: Chiesi Farmaceutici
Chairman and Advocate: Peter R. Byron, Ph.D.

3.30 p.m.

Deposition Equivalence through DoE and Impaction Parameter Matching
Andrew R. Clark, Ph.D.,
Aerogen Pharma, San Mateo, California USA

3.50 p.m.

Flow Rate Dependence of Powder Inhalers: The Importance of the Q-Index
Jeffry Weers, Ph.D.,
Scientific Consultant, Half Moon Bay, California, USA

4.10 p.m.

Comparing Aerosol Capture in 8 Mouth-throat Models for a DPI, MDI and SMI
Dennis Sandell, Ph.D.,
S5 Consulting, Blentarp, Sweden

4.30 p.m.

Old Throats for New: A Curve Ball Posed by New USP Product Monographs
Jolyon P. Mitchell, Ph.D. (Delivered via Teleconference),
Scientific Consultant, London, Ontario, Canada

4.50 p.m.

Panel Discussion
Chairperson and Advocate: Peter R. Byron, Ph.D.
Virginia Commonwealth University, Richmond, Virginia, USA

Panel:
Elise Burmeister-Getz, Oriel Therapeutics
Andrew R. Clark, Aerogen Pharma
Jolyon P. Mitchell, Scientific Consultant
Dennis Sandell, S5 Consulting
Jeffry Weers, Novartis

5.30 p.m.

End of Discussion Forum

7.00 p.m.

Gala Dinner

Sponsored by Aptar Pharma

The Gala Dinner will be held at the Palm Beach, Cannes, famous for the International Film Festival, and will feature multicultural cuisine, entertainment, dancing and networking with other delegates.

 
Alerts & Reminders

Delegates

Please complete your conference evaluation

Details of your online access to RDD proceedings will be sent to you by email before 1st June 2017.


Links

RDD Europe 2017 is a conference organized jointly by
RDD OnlineAptar Pharma
www.rddonline.com - Copyright 1998-2017 - All Rights Reserved - Legal